
From 4 August, sexual health clinics in England have been able to offer a free vaccine – the 4CMenB vaccine …

Freya Pharma Solutions has announced the initiation of a phase 2 study evaluating its Lybrido to treat female sexual interest/arousal …

Johnson & Johnson has submitted an application to the European Medicines Agency for an indication extension of Akeega (niraparib and …
First-in-class therapeutic peptide BZ371A confirmed as effective and well-tolerated 20 May 2025. Another Day Pharma Ltd, a company developing innovative …

Belgian specialty biopharmaceutical company Hyloris has announced that it has enrolled the first patient in its four-arm interstitial cystitis/bladder pain …